相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL
Adam S. Kittai et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Ronan T. Swords et al.
BLOOD (2018)
Ibrutinib blocks Btk-dependent NF-κB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis
Amelia Bercusson et al.
BLOOD (2018)
The Balance of Th17 versus Treg Cells in Autoimmunity
Gap Ryol Lee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Differential Roles of IL-2 Signaling in Developing versus Mature Tregs
Martin Y. Fan et al.
CELL REPORTS (2018)
Signaling and Function of Interleukin-2 in T Lymphocytes
Sarah H. Ross et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Ibrutinib treatment improves T cell number and function in CLL patients
Meixiao Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia
Qingsong Yin et al.
JOURNAL OF IMMUNOLOGY (2017)
Molecular mechanisms underlying Th1-like Treg generation and function
Alexandra Kitz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma
Jatin J. Shah et al.
CLINICAL CANCER RESEARCH (2016)
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Benjamin L. Lampson et al.
BLOOD (2016)
Drugging the undruggables: exploring the ubiquitin system for drug development
Xiaodong Huang et al.
CELL RESEARCH (2016)
MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma
Yi Zhang et al.
ONCOTARGET (2016)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells
J. Claire Godbersen et al.
LEUKEMIA & LYMPHOMA (2015)
Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents
C. Paiva et al.
CELL DEATH & DISEASE (2015)
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53
Polina Shindiapina et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
J. Claire Godbersen et al.
CLINICAL CANCER RESEARCH (2014)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky et al.
BLOOD (2013)
Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide
Alan G. Ramsay et al.
BLOOD (2013)
Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924
Jonathan L. Blank et al.
CANCER RESEARCH (2013)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Understanding the Immunodeficiency in Chronic Lymphocytic Leukemia Potential Clinical Implications
John C. Riches et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
NF-κB: roles and regulation in different CD4+ T-cell subsets
Hyunju Oh et al.
IMMUNOLOGICAL REVIEWS (2013)
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
DJ DiLillo et al.
LEUKEMIA (2013)
The Discovery of a Reciprocal Relationship between Tyrosine-Kinase Signaling and Cullin Neddylation
Samantha F. Friend et al.
PLOS ONE (2013)
Neddylation pathway regulates T-cell function by targeting an adaptor protein Shc and a protein kinase Erk signaling
Hyung-seung Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A new look at T cell receptor signaling to nuclear factor-κB
Suman Paul et al.
TRENDS IN IMMUNOLOGY (2013)
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Eric V. Dang et al.
CELL (2011)
The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production
Erxia Shen et al.
CELL BIOLOGY INTERNATIONAL (2011)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Nuclear Factor-κB Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor
Meixiao Long et al.
IMMUNITY (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A. Koch et al.
NATURE IMMUNOLOGY (2009)
STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells
Laura Passerini et al.
INTERNATIONAL IMMUNOLOGY (2008)
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia
Sebastian Francis et al.
CANCER (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
G Görgün et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Interleukin 2 plays a central role in Th2 differentiation
J Cote-Sierra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy
AM Krackhardt et al.
BLOOD (2002)
Adjuvant activities of immune response modifier R-848: Comparison with CpG ODN
JP Vasilakos et al.
CELLULAR IMMUNOLOGY (2000)
分享论文
